• PROGENICS PHARMACEUTICALS IN Analyst Recommendations

  • Analyst Consensus: PGNX

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.091 Buy 11
    30 Days Ago 2.091 Buy 11
    60 Days Ago 2.071 Buy 14
    90 Days Ago 2.067 Buy 15
    120 Days Ago 2.200 Buy 15

  • Analyst Ratings: PGNX

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    RBC Capital Mkts — Outperform 08/11/2008 21.00
    Friedman Billings Underperform — 07/10/2008 —
    Friedman Billings Mkt Perform Underperform 07/02/2008 12.00
    Ladenburg Thalmann — Buy 06/06/2008 40.00
    Brean Murray — Buy 05/22/2008 20.00
    Citigroup Sell Hold 04/25/2008 —
    Friedman Billings — Mkt Perform 04/25/2008 9.00
    RBC Capital Mkts — Outperform 03/13/2008 10.00
    Punk, Ziegel & Co — Buy 03/12/2008 15.00
    Friedman Billings Outperform Mkt Perform 03/12/2008 8.00
    Brean Murray — Buy 03/12/2008 15.00
    Lazard Capital Buy Hold 03/12/2008 —
    Lazard Capital — Buy 01/10/2008 32.00
    Broadpoint Capital — Buy 11/08/2007 30.00
    Lazard Capital — Buy 05/01/2007 37.00
    Punk, Ziegel & Co — Buy 04/02/2007 38.00
    Lazard Capital — Buy 03/07/2007 32.00
    Punk, Ziegel & Co — Buy 03/07/2007 38.00
    CIBC Wrld Mkts — Sector Outperform 03/07/2007 31.00
    Friedman Billings — Outperform 03/07/2007 35.00
    Friedman Billings — Outperform 02/14/2007 38.00
    RBC Capital Mkts Sector Perform Outperform 01/29/2007 35.00
    First Albany — Buy 12/22/2006 33.00
    Am Tech/JSA Research — Buy 11/06/2006 36.00
    WR Hambrecht — Hold 09/14/2006 —
    Piper Jaffray — Outperform 08/22/2006 31.00
    Cowen & Co — Outperform 08/02/2006 —
    RBC Capital Mkts — Sector Perform 07/27/2006 —
    Punk, Ziegel & Co — Buy 04/24/2006 37.00
    Punk, Ziegel & Co — Buy 03/15/2006 41.00
    Next